Abstracting and Indexing

• PubMed NLM
• Google Scholar
• Semantic Scholar
• Scilit
• CrossRef
• WorldCat
• ResearchGate
• Academic Keys
• DRJI
• Microsoft Academic
• Academia.edu
• OpenAIRE
• Scribd
• Baidu Scholar

Millions of people worldwide suffer from tendinopathy, which poses a serious clinical problem and contributes significantly to morbidity in both general and sporty populations. Interest in regenerative medicine techniques has grown as a result of the poor long-term effectiveness of traditional conservative therapies. With an emphasis on platelet-rich plasma (PRP), mesenchymal stem cell therapy, and new biological treatments, this review looks at the state of regenerative therapeutics for tendinopathy. We examine these therapy approaches' mechanisms of action, clinical evidence, pathophysiology justification, and potential future possibilities. Despite encouraging reports, clinical translation remains difficult due to variations in patient selection, treatment procedures, and outcome metrics. This review summarises the available data and offers suggestions for future lines of inquiry in the management of regenerated tendinopathy.